These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 38716657

  • 1. Cardiovascular Outcomes in Hypertension-Treated Patients With Peripheral Artery Disease: The VALUE Trial.
    Vrsalovic M, Heimark S, Søraas CL, Mehlum MH, Kjeldsen SE, Mancia G, Julius S, Weber MA.
    Hypertension; 2024 Jul; 81(7):1628-1636. PubMed ID: 38716657
    [Abstract] [Full Text] [Related]

  • 2. No evidence for a J-shaped curve in treated hypertensive patients with increased cardiovascular risk: The VALUE trial.
    Kjeldsen SE, Berge E, Bangalore S, Messerli FH, Mancia G, Holzhauer B, Hua TA, Zappe D, Zanchetti A, Weber MA, Julius S.
    Blood Press; 2016 Jul; 25(2):83-92. PubMed ID: 26511535
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Characteristics and long-term follow-up of participants with peripheral arterial disease during ALLHAT.
    Piller LB, Simpson LM, Baraniuk S, Habib GB, Rahman M, Basile JN, Dart RA, Ellsworth AJ, Fendley H, Probstfield JL, Whelton PK, Davis BR, ALLHAT Collaborative Research Group.
    J Gen Intern Med; 2014 Nov; 29(11):1475-83. PubMed ID: 25002161
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. VALUE trial: Long-term blood pressure trends in 13,449 patients with hypertension and high cardiovascular risk.
    Julius S, Kjeldsen SE, Brunner H, Hansson L, Platt F, Ekman S, Laragh JH, McInnes G, Schork AM, Smith B, Weber M, Zanchetti A, VALUE Trial.
    Am J Hypertens; 2003 Jul; 16(7):544-8. PubMed ID: 12850387
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Cardiovascular outcomes at different on-treatment blood pressures in the hypertensive patients of the VALUE trial.
    Mancia G, Kjeldsen SE, Zappe DH, Holzhauer B, Hua TA, Zanchetti A, Julius S, Weber MA.
    Eur Heart J; 2016 Mar 21; 37(12):955-64. PubMed ID: 26590384
    [Abstract] [Full Text] [Related]

  • 14. Outcomes in subgroups of hypertensive patients treated with regimens based on valsartan and amlodipine: An analysis of findings from the VALUE trial.
    Zanchetti A, Julius S, Kjeldsen S, McInnes GT, Hua T, Weber M, Laragh JH, Plat F, Battegay E, Calvo-Vargas C, Cieśliński A, Degaute JP, Holwerda NJ, Kobalava J, Pedersen OL, Rudyatmoko FP, Siamopoulos KC, Störset O.
    J Hypertens; 2006 Nov 21; 24(11):2163-8. PubMed ID: 17053536
    [Abstract] [Full Text] [Related]

  • 15. Effectiveness of amlodipine-valsartan single-pill combinations: hierarchical modeling of blood pressure and total cardiovascular disease risk outcomes (the EXCELLENT study).
    Lins R, Aerts A, Coen N, Hermans C, MacDonald K, Brié H, Lee C, Shen YM, Vancayzeele S, Mecum N, Abraham I.
    Ann Pharmacother; 2011 Jun 21; 45(6):727-39. PubMed ID: 21666094
    [Abstract] [Full Text] [Related]

  • 16. Comparison between valsartan and amlodipine regarding cardiovascular morbidity and mortality in hypertensive patients with glucose intolerance: NAGOYA HEART Study.
    Muramatsu T, Matsushita K, Yamashita K, Kondo T, Maeda K, Shintani S, Ichimiya S, Ohno M, Sone T, Ikeda N, Watarai M, Murohara T, NAGOYA HEART Study Investigators.
    Hypertension; 2012 Mar 21; 59(3):580-6. PubMed ID: 22232134
    [Abstract] [Full Text] [Related]

  • 17. On-Treatment Blood Pressure and Cardiovascular Outcomes in Older Adults With Isolated Systolic Hypertension.
    Yano Y, Rakugi H, Bakris GL, Lloyd-Jones DM, Oparil S, Saruta T, Shimada K, Matsuoka H, Imai Y, Ogihara T.
    Hypertension; 2017 Feb 21; 69(2):220-227. PubMed ID: 28049699
    [Abstract] [Full Text] [Related]

  • 18. Predictors of cardiac morbidity in diabetic, new-onset diabetic and non-diabetic high-risk hypertensive patients: The Valsartan Antihypertensive Long-term Use Evaluation (VALUE) trial.
    Aksnes TA, Kjeldsen SE, Rostrup M, Holzhauer B, Hua TA, Julius S.
    Blood Press; 2016 Aug 21; 25(4):235-40. PubMed ID: 26808585
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension.
    Poldermans D, Glazes R, Kargiannis S, Wernsing M, Kaczor J, Chiang YT, Yen J, Gamboa R, Fomina I.
    Clin Ther; 2007 Feb 21; 29(2):279-89. PubMed ID: 17472820
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.